Related Experiment Videos
Orally active amino functionalized antimalarial 1,2,4-trioxanes.
Chandan Singh1, Heetika Malik, Sunil K Puri
1Division of Medicinal Chemistry, Central Drug Research Institute, -226001, Lucknow, India. chandancdri@yahoo.com
Bioorganic & Medicinal Chemistry Letters
|December 31, 2003
Summary
New amino-functionalized 1,2,4-trioxanes show promising antimalarial activity. Compound 9a is highly potent against drug-resistant malaria in mice, approaching the efficacy of beta-arteether.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Drug Discovery
Background:
- Antimalarial drug resistance is a significant global health challenge.
- 1,2,4-trioxanes are a class of compounds with known antimalarial properties.
- Development of novel antimalarial agents is crucial.
Purpose of the Study:
- To synthesize and evaluate novel amino-functionalized 1,2,4-trioxanes.
- To assess the antimalarial activity of these compounds against drug-resistant Plasmodium yoelii.
- To identify potent antimalarial candidates for further development.
Main Methods:
- Synthesis of amino-functionalized 1,2,4-trioxanes (compounds 8a-e and 9a-e) from trioxanes 6a-b.
- In vivo antimalarial activity evaluation in a Swiss mice model.
- Testing against multi-drug resistant Plasmodium yoelii strains.
Main Results:
- Several novel amino-functionalized trioxanes demonstrated significant antimalarial activity.
- Compounds showed improved oral activity compared to parent trioxanes.
- Amino-functionalized trioxane 9a exhibited the highest potency, comparable to beta-arteether.
Conclusions:
- Amino-functionalized 1,2,4-trioxanes represent a promising new class of antimalarial agents.
- Compound 9a is a highly effective antimalarial candidate against resistant malaria.
- Further research into this series could lead to new malaria treatments.